FRAGMIN- dalteparin sodium injection

Pfizer Inc.

FRAGMIN is a low molecular weight heparin (LMWH) indicated for

• Prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction (1.1)

• Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery or medical patients with severely restricted mobility during acute illness (1.2)

• Extended treatment of symptomatic venous thromboembolism (VTE) to reduce the recurrence in adult patients with cancer. In these patients, the FRAGMIN therapy begins with the initial VTE treatment and continues for six months (1.3)

• Treatment of symptomatic venous thromboembolism (VTE) to reduce the recurrence in pediatric patients from birth (gestational age at least 35 weeks) (1.4)

• Limitations of Use
FRAGMIN is not indicated for the acute treatment of VTE (1.5)

Store at 20°C to 25°C (68°F to 77°F); excursion permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].